NCT04890262View on ClinicalTrials.gov

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

CompletedOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Inflammatory Bowel DiseasesCrohns DiseaseColitis, Ulcerative
Trial Locations (7)

1090

Medizinische Universitat Wien, Vienna

4021

JKU Linz, Linz

4600

Klinikum Wels-Grieskirchen GmbH, Wels

5020

Darmpraxis Salzburg, Salzburg

6020

Medizinische Universitat Innsbruck, Innsbruck

8036

Medizinische Universitat Graz, Graz

9300

Krankenhaus der Barmherzigen Bruder, Saint Veit/Glan

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY